Accelerating Clinical Next-Generation Sequencing: Navigating the Path to Reimbursement | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« Developments in CRISPR Patent Dispute: EPO Revokes Broad’s CRISPR Patent

What Level of Blood Pressure (BP) should be Treated? Comments on the New Guidelines »

Accelerating Clinical Next-Generation Sequencing: Navigating the Path to Reimbursement

January 23, 2018 by 2012pharmaceutical

Accelerating Clinical Next-Generation Sequencing: Navigating the Path to Reimbursement

Reporter: Aviva Lev-Ari, PhD, RN

Session at PMWC 2018 Silicon Valley

http://www.pmwcintl.com/sessionthemes-accelerating-clinical-next-generation-sequencing-2018sv/

Posted in Diagnostic Immunology, Diagnostics and Lab Tests, Liquid Biopsy: Circulating Tumor Cells in Urine and Blood, Next Generation Sequencing (NGS) | Leave a Comment

Leave a ReplyCancel reply

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Email Address

Join 9,319 other subscribers
Recent Posts
Archives
Archives
Categories
Categories
Meta

%d bloggers like this: